UnitedHealth Group’s diversified Optum segment reported fourth-quarter revenue of $54.3 billion, up 11.8% year-over-year, driven primarily by a 16.2% increase in OptumHealth services and a 9.4% gain in OptumInsight technology offerings. The pharmacy care services arm within OptumRx processed 265 million prescriptions during the quarter, representing a 7.5% volume increase compared with the prior year. This broad mix of care delivery, consulting and pharmacy management businesses now contributes more than 50% of total company operating profit, underscoring UnitedHealth’s ability to offset underwriting pressure in its core insurance operations.

In its January earnings release, UnitedHealth reported net income of $6.1 billion, or $8.12 per share, for the quarter, compared with $5.4 billion, or $7.10 per share, in the prior year period. The company’s consolidated medical care ratio improved by 120 basis points to 81.3%, reflecting a disciplined claims management process and targeted care coordination initiatives that have lowered utilization per member. Administrative expense ratio held steady at 13.5%, as investments in automated claims adjudication and digital member engagement platforms delivered operating efficiencies.

With policy uncertainty around reimbursement rates and proposed changes to benefit design in several key states, UnitedHealth’s 53 million commercial and Medicare Advantage enrollees provide a buffer against regional headwinds. The company reiterated its full-year guidance for mid-single-digit revenue growth and adjusted operating margin of 6.9% to 7.1%, citing its scale advantages in negotiating network discounts and pricing new business. Management also emphasized a $5.0 billion share repurchase authorization remaining under the current buyback program, reflecting confidence in cash generation even as state regulators consider tighter rate review processes.